Ivabradin

Ivabradin is a medication approved for conditions other than Long Covid, but is now being covered by German health insurance for off-label use in treating Long Covid symptoms. This development is newsworthy because, previously, Long Covid patients in Germany faced difficulties getting medication costs reimbursed by health insurance. The Gemeinsame Bundesausschuss (G-BA), a German committee, decided that certain medications, including Ivabradin, will now be covered for Long Covid patients despite not being specifically approved for that condition. This decision is significant because it provides financial relief and access to potential symptom management for Long Covid sufferers in Germany, although it's important to note that these medications are not a cure for the disease, but rather aim to alleviate specific symptoms.